April 2017 FDA Recall Drug by American Pharmaceutical Ingredients Llc
D-0919-2017 - cGMP Deviations; lack of quality assurance.

This Class II drug recall was voluntarily initiated by American Pharmaceutical Ingredients Llc on April 17, 2017 for the product Drug. The FDA reported the reason for recall as cgmp deviations; lack of quality assurance.. The product was distributed in NY, GA, NV, CA, KY, TX and the recall is currently terminated.

Recall Number: D-0919-2017

Reason for Recall
cGMP Deviations; lack of quality assurance.
Initiated
04-17-2017
Reported
06-21-2017
Quantity
1g=1 bottle; 5g=4 bottle; 25g=3 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
American Pharmaceutical Ingredients LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
NY, GA, NV, CA, KY, TX
ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Batch or Lot Expiration Information

Lot# Lots: 052915-1, 052915-2, exp 5/5/2017